CP

Chemmancherry Puthiyaveedu Binesh

Active Director Director DIN 09606204
DIN 09606204 First appointment May 2022 Primary industry Research & Development
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Chemmancherry Puthiyaveedu Binesh

Data last updated:

Chemmancherry Puthiyaveedu Binesh is a Director at Genescope Research And Services Private Limited (since 2022). The company operates in Research & Development.

DIN 09606204
Primary Designation Director
Industry Research & Development
First Appointment 13 May 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 May 20222022Active

Board colleagues of Chemmancherry Puthiyaveedu Binesh

Directorship timeline

Open interactive timeline →
Genescope Research And Services Private Limited
Premium access

Shareholding and investment profile for Chemmancherry Puthiyaveedu Binesh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chemmancherry Puthiyaveedu Binesh

Chemmancherry Puthiyaveedu Binesh currently holds 1 directorship: Genescope Research And Services Private Limited (Director, since 13 May 2022).

Chemmancherry Puthiyaveedu Binesh was first appointed on 13 May 2022 as Director at Genescope Research And Services Private Limited.

The current boards of Chemmancherry Puthiyaveedu Binesh's companies include Greeshma Chovva (Genescope Research And Services Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available